Determinants for Substrate Selectivity of the Hepatitis C Virus NS3-4A Protease

被引：0
|
作者：
Tran, Huong T. L. [1 ]
Gouttenoire, Jerome [1 ]
Moradpour, Darius [1 ]
机构：
[1] Univ Lausanne, Div Gastroenterol & Hepatol, CHUV, CH-1011 Lausanne, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2013年 / 143卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
28
引用
收藏
页码：8S / 8S
页数：1
相关论文
共 50 条
  • [41] Hepatitis C virus NS3/4a protease inhibitors
    McCauley, John A.
    Rudd, Michael T.
    CURRENT OPINION IN PHARMACOLOGY, 2016, 30 : 84 - 92
  • [42] Fluorescence Resonance Energy Transfer-Based Assay for Characterization of Hepatitis C Virus NS3-4A Protease Activity in Live Cells
    Sabariegos, Rosario
    Picazo, Fernando
    Domingo, Beatriz
    Franco, Sandra
    Martinez, Miguel-Angel
    Llopis, Juan
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (02) : 728 - 734
  • [43] HEPATITIS C VIRUS NS3-4A PROTEASE TARGETS THE HOST FACTOR BNIP1 AT A NON-CANONICAL CLEAVAGE SITE
    Tran, H. Thi Lan
    Morikawa, K.
    Penin, F.
    Quadroni, M.
    Gouttenoire, J.
    Moradpour, D.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S578 - S578
  • [44] Enzymatic characterization of membrane-associated hepatitis C virus NS3-4A heterocomplex serine protease activity expressed in human cells
    Hamill, P
    Jean, F
    BIOCHEMISTRY, 2005, 44 (17) : 6586 - 6596
  • [45] Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease
    Perni, RB
    Almquist, SJ
    Byrn, RA
    Chandorkar, G
    Chaturvedi, PR
    Courtney, LF
    Decker, CJ
    Dinehart, K
    Gates, CA
    Harbeson, SL
    Heiser, A
    Kalkeri, G
    Kolaczkowski, E
    Lin, K
    Luong, YP
    Rao, BG
    Taylor, WP
    Thomson, JA
    Tung, RD
    Wei, YY
    Kwong, AD
    Lin, C
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (03) : 899 - 909
  • [46] Sustained virological response in a patient with chronic hepatitis C treated by monotherapy with the NS3-4A protease inhibitor telaprevir
    Suzuki, Fumitaka
    Suzuki, Yoshiyuki
    Akuta, Norio
    Sezaki, Hitomi
    Yatsuji, Hiromi
    Arase, Yasuji
    Hirakawa, Miharu
    Kawamura, Yusuke
    Hosaka, Tetsuya
    Kobayashi, Masahiro
    Saito, Satoshi
    Ikeda, Kenji
    Kobayashi, Mariko
    Watahiki, Sachiyo
    Mineta, Rie
    Iwasaki, Satomi
    Kumada, Hiromitsu
    JOURNAL OF CLINICAL VIROLOGY, 2010, 47 (01) : 76 - 78
  • [47] SUCCESSFUL ELIMINATION OF HEPATITIS C VIRUS BY NS3-4A PROTEASE/NS5B POLYMERASE INHIBITORS COMBINATION THERAPY IN HUMAN HEPATOCYTE CHIMERIC MICE
    Hiraga, Nobuhiko
    Ohara, Eiji
    Imamura, Michio
    Iwao, Eiji
    Mitsui, Fukiko
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Takahashi, Shoichi
    Abe, Hiromi
    Hayes, C. Nelson
    Ochi, Hidenori
    Tateno, Chise
    Yoshizato, Katsutoshi
    Chayama, Kazuaki
    HEPATOLOGY, 2010, 52 (04) : 1202A - 1202A
  • [48] The hepatitis C virus NS2/3 protease
    Welbourn, Sarah
    Pause, Arnim
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2007, 9 : 63 - 69
  • [49] Structure-activity relationships for the selectivity of hepatitis C virus NS3 protease inhibitors
    Poliakov, A
    Johansson, A
    Åkerblom, E
    Oscarsson, K
    Samuelsson, B
    Hallberg, A
    Danielson, UH
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2004, 1672 (01): : 51 - 59
  • [50] Molecular basis of telaprevir resistance due to V36 and T54 mutations in the NS3-4A protease of the hepatitis C virus
    Welsch, Christoph
    Domingues, Francisco S.
    Susser, Simone
    Antes, Iris
    Hartmann, Christoph
    Mayr, Gabriele
    Schlicker, Andreas
    Sarrazin, Christoph
    Albrecht, Mario
    Zeuzem, Stefan
    Lengauer, Thomas
    GENOME BIOLOGY, 2008, 9 (01)
12345